|drug231||Conventional medicines (Oxygen therapy, alfa interferon via aerosol inhalation, and lopinavir/ritonavir) Wiki||1.00|
There is one clinical trial.
The aim of this study is to test whether Traditional Chinese Medicines (TCMs) are effective and safe for treating 2019-nCoV infection. After the enrolment of approximately 30 subjects, the recruitment will be paused, and planned interim analysis will be performed to preliminarily investigate the efficacy and safety of TCMs in patients infected with 2019-nCoV.
Description: Symptoms associated with 2019-nCoV infection involve fever and cough.Measure: Time to complete remission of 2019-nCoV infection-associated symptoms Time: 28 days
Description: In eligible subjects, the oxygen saturation level is less than 94%, and the respiratory rate is more than 24 breaths per min.Measure: The incidence of dyspnea with low oxygen saturation level and high respiratory rate Time: 28 days
Description: Number of subjects who develop complications, including acute respiratory distress syndrome (ARDS), RNAaemia, acute cardiac injury, acute kidney injury (AKI), secondary infection and shock, will be described.Measure: Number of subjects who develop complications of 2019-nCoV infection Time: 28 days
Description: Virus shedding was detected twice at least a day apart.Measure: Time to virus shedding Time: 28 days
Description: improvement of chest radiographic evidence indirectly reflects recovery in patients infected with 2019-nCoV.Measure: Time to improvement of abnormalities in Chest radiology Time: 28 days
Description: The changes of TCM symptoms before and after treatment reveal the effect of TCM treatment for 2019-nCoV infection.Measure: The evaluation of Traditional Chinese Medicine (TCM) symptoms before and after treatment Time: 28 days
Description: The rate of subject who die will be described.Measure: Rate of subjects who die Time: 28 days
Description: The rate of subjects with severe 2019-nCoV infection who receive systematic corticosteroids will be described.Measure: Rate of subjects receiving systematic corticosteroids Time: 28 days
Description: The length of hospital staysMeasure: The length of hospital stays Time: 28 days
Description: The duration of respiratory support including invasive and non-invasive mechanical ventilationMeasure: The duration of respiratory support Time: 28 days